清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications

作者
James R. O’Dell,Claire E. Haire,Nils Erikson,Walter Drymalski,WILLIAM R. PALMER,P. James Eckhoff,Vernon Garwood,Pierre A. Maloley,Lynell W. Klassen,Steven J. Wees,Harry S. Klein,Gerald Moore
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:334 (20): 1287-1291 被引量:655
标识
DOI:10.1056/nejm199605163342002
摘要

BACKGROUND: Rheumatoid arthritis is a common disease that causes substantial morbidity and mortality. The responses of patients with rheumatoid arthritis to treatment with a single so-called disease-modifying drug, such as methotrexate, are often suboptimal. Despite limited data, many patients are treated with combinations of these drugs. METHODS: We enrolled 102 patients with rheumatoid arthritis and poor responses to at least one disease-modifying drug in a two-year, double-blind, randomized study of treatment with methotrexate alone (7.5 to 17.5 mg per week), the combination of sulfasalazine (500 mg twice daily) and hydroxychloroquine (200 mg twice daily), or all three drugs. The dose of methotrexate was adjusted in an attempt to achieve remission in all patients. The primary and point of the study was the successful completion of two years of treatment with 50 percent improvement in composite symptoms of arthritis and no evidence of drug toxicity. RESULTS: Fifty of the 102 patients had 50 percent improvement at nine months and maintained at least that degree of improvement for two years without evidence of major drug toxicity. Among them were 24 of 31 patients treated with all three drugs (77 percent), 12 of 36 patients treated with methotrexate alone (33 percent, P < 0.001 for the comparison with the three-drug group), and 14 of 35 patients treated with sulfasalazine and hydroxychloroquine (40 percent), P = 0.003 for the comparison with the three-drug group). Seven patients in the methotrexate group and three patients in each of the other two groups discontinued treatment because of drug toxicity. CONCLUSIONS: In patients with rheumatoid arthritis, combination therapy with methotrexate, sulfasalazine, and hydroxychloroquine is more effective than either methotrexate alone or a combination of sulfasalazine, and hydroxychloroquine.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
14秒前
JUN完成签到,获得积分10
21秒前
瞿人雄完成签到,获得积分10
26秒前
没心没肺完成签到,获得积分10
30秒前
Jasper的应助被科研通管家采纳,获得10
32秒前
32秒前
丘比特的应助被科研通管家采纳,获得10
32秒前
上官若男的应助被科研通管家采纳,获得10
32秒前
Ava的应助被科研通管家采纳,获得10
32秒前
大意的之柔完成签到,获得积分10
35秒前
37秒前
40秒前
369ninja发布了新的文献求助10
45秒前
可靠往事完成签到,获得积分10
47秒前
自由的梦山完成签到,获得积分10
57秒前
喜悦如萱完成签到,获得积分10
1分钟前
1分钟前
1分钟前
369ninja发布了新的文献求助10
1分钟前
1分钟前
学霸业的应助被369ninja采纳,获得10
1分钟前
369ninja发布了新的文献求助10
1分钟前
1分钟前
43tg完成签到,获得积分10
1分钟前
qfhbg完成签到,获得积分10
2分钟前
落后哈密瓜完成签到,获得积分10
2分钟前
wetg完成签到,获得积分10
2分钟前
学霸业的应助被369ninja采纳,获得10
2分钟前
portik完成签到,获得积分10
2分钟前
要减肥的菀完成签到,获得积分10
2分钟前
hgjk完成签到,获得积分10
2分钟前
2分钟前
sdf完成签到,获得积分10
2分钟前
VDC的应助被369ninja采纳,获得30
2分钟前
amz完成签到,获得积分10
2分钟前
adefgv完成签到,获得积分10
2分钟前
科目三的应助被科研通管家采纳,获得10
2分钟前
fhjg完成签到,获得积分10
2分钟前
Nole的应助被369ninja采纳,获得10
2分钟前
jtk完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179961
求助须知:如何正确求助?哪些是违规求助? 9570183
关于积分的说明 21808480
捐赠科研通 7775832
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557373
邀请新用户注册赠送积分活动 2478958